Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.45
-0.09 (-2.54%)
At close: Oct 16, 2025, 3:59 PM
3.42
-0.87%
After-hours: Oct 16, 2025, 07:30 PM EDT
-2.54% (1D)
| Bid | 3.45 |
| Market Cap | 2.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.33M |
| EPS (ttm) | 41.76 |
| PE Ratio (ttm) | 0.08 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.56 |
| Volume | 111,183 |
| Avg. Volume (20D) | 2,116,226 |
| Open | 3.50 |
| Previous Close | 3.54 |
| Day's Range | 3.42 - 3.58 |
| 52-Week Range | 2.36 - 82.80 |
| Beta | 0.24 |
| Ex-Dividend Date | n/a |
2 months ago
-6.85%
PBM stock has given up its prior gain. Psyence Bio...
Unlock content with
Pro Subscription
2 months ago
-6.85%
Psyence Biomedical shares are trading higher after the company announced it, along with PsyLabs, achieved a breakthrough in GMP-aligned high-purity ibogaine production.
